Publicacións en colaboración con investigadores/as de Complejo Hospitalario de Toledo (21)

2020

  1. TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors

    Neuro-Oncology Advances, Vol. 2, Núm. 1

2015

  1. Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation

    Haematologica, Vol. 100, Núm. 5, pp. e200-e203

  2. Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients

    Journal of Neuro-Oncology, Vol. 122, Núm. 3, pp. 441-450

  3. Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade

    Journal of Neuropathology and Experimental Neurology, Vol. 74, Núm. 3, pp. 241-249

2014

  1. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation

    Leukemia, Vol. 28, Núm. 6, pp. 1334-1340

2013

  1. Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors

    Acta Neuropathologica, Vol. 126, Núm. 2, pp. 277-289

2012

  1. Genetic alterations associated with progression and recurrence in meningiomas

    Journal of Neuropathology and Experimental Neurology, Vol. 71, Núm. 10, pp. 882-893

  2. MRNA in situ hybridization (HistoSonda): A new diagnostic tool for HER2-Status in breast cancer-A multicentric spanish study

    Diagnostic Molecular Pathology, Vol. 21, Núm. 2, pp. 84-92

2010

  1. Amolecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

    Blood, Vol. 116, Núm. 8

  2. Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas

    Neuro-Oncology, Vol. 12, Núm. 12, pp. 1278-1290

2009

  1. Novel genomic alterations and mechanisms associated with tumor progression in oligodendroglioma and mixed oligoastrocytoma

    Journal of Neuropathology and Experimental Neurology, Vol. 68, Núm. 3, pp. 274-285

  2. Splenic follicular lymphoma: Clinicopathologic characteristics of a series of 32 cases

    American Journal of Surgical Pathology, Vol. 33, Núm. 5, pp. 730-738

2008

  1. Identification of survival-related genes of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma multiforme

    Cancer, Vol. 112, Núm. 7, pp. 1575-1584

2006

  1. BCR gene disruption in a pilomyxoid astrocytoma

    Neuropathology, Vol. 26, Núm. 5, pp. 442-446

  2. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling

    Molecular Cancer, Vol. 5

2005

  1. Large B-cell lymphoma with Hodgkin's features

    Histopathology, Vol. 47, Núm. 1, pp. 101-110

2004

  1. Building an Outcome Predictor Model for Diffuse Large B-Cell Lymphoma

    American Journal of Pathology, Vol. 164, Núm. 2, pp. 613-622

2003

  1. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: Analyses using tissue microarrays

    Blood, Vol. 101, Núm. 2, pp. 681-689

2001

  1. Primary cutaneous large B-cell lymphoma: The relation between morphology, clinical presentation, immunohistochemical markers, and survival

    American Journal of Surgical Pathology, Vol. 25, Núm. 3, pp. 307-315

1995

  1. Mucosal mantle cell (centrocytic) lymphomas

    Histopathology, Vol. 26, Núm. 5, pp. 413-422